{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:19:26Z","timestamp":1787775566498,"version":"build-2784847793"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:00:00Z","timestamp":1720742400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background &amp; objectives:<\/jats:title>\n                    <jats:p>More than 1 million people die every year from vector-borne diseases, which constitute more than 17% of all infectious diseases. This study\u2019s primary focus was on the detailed evolutionary history and expression analysis of immune genes, one of the key gene families in the immune system of vectors that play a role in the regulation and interaction of parasites in vector bodies, particularly the mosquitoes that transmit malaria and dengue, the two most significant vector-borne diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The vector potentiality and participation of TLR genes in vector parasite interaction in the Indian context is explained by the differential expression study of this potential gene family in Indian population of vector species.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>This knowledge undoubtedly supports for creating new pharmacological targets and inhibitors that can create insect-based transmission-stopping techniques for many vector-borne diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interpretation &amp; conclusion:<\/jats:title>\n                    <jats:p>\n                      However, the genetic diversity was found to be comparatively lower in the TolllA gene than in the NOS immune gene in the malaria vector\n                      <jats:italic toggle=\"yes\">Anopheles minimus<\/jats:italic>\n                      population samples which supports the hypothesis of positive selection in recent evolutionary time scale in malaria vectors. This is one of the novel strategies to identify transmission-regulating genetic traits that control vector-parasite interaction and co-evolution in vector-borne diseases.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jvbd.jvbd_157_23","type":"journal-article","created":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T10:43:20Z","timestamp":1721904200000},"page":"88-92","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Transmission regulating immune genes: A potential strategy to control vector-borne disease"],"prefix":"10.4103","volume":"62","author":[{"given":"Hemlata","family":"Srivastava","sequence":"first","affiliation":[{"name":"Department of Biosciences, Institute of Management Studies Ghaziabad (University Courses Campus), India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavna","family":"Gupta","sequence":"additional","affiliation":[{"name":"ICMR-Vector Control Research Centre Field Station, Madurai, TN, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Irfan","family":"Ali","sequence":"additional","affiliation":[{"name":"School of Allied Health Sciences, JECRC University, Jaipur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarmad","family":"Moin","sequence":"additional","affiliation":[{"name":"School of Applied Sciences, Suresh Gyan Vihar University, Jaipur, Rajasthan, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7,12]]},"reference":[{"key":"R2-20250307","first-page":"2017","article-title":"Global Vector Control Response","year":"2020"},{"key":"R3-20250307","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.medmal.2011.07.016","article-title":"Transmission parameters of vector-borne infections","volume":"41","author":"Desenclos","year":"2011","journal-title":"Med Mal Infect"},{"key":"R4-20250307","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.3390\/v5123021","article-title":"Vector-Virus Interactions and Transmission Dynamics of West Nile Virus","volume":"5","author":"Ciota","year":"2013","journal-title":"Viruses"},{"key":"R5-20250307","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2049-9957-3-1","article-title":"Control of malaria and other vector-borne protozoan diseases in the tropics: enduring challenges despite considerable progress and achievements","volume":"3","author":"Zofou","year":"2014","journal-title":"Infectious Diseases of poverty"},{"key":"R6-20250307","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parint.2008.07.004","article-title":"Sandflies, Leishmania and transcriptome-borne solutions","volume":"58","author":"Oliveira","year":"2009","journal-title":"Parasitol Int"},{"key":"R7-20250307","doi-asserted-by":"crossref","first-page":"e2636","DOI":"10.1371\/journal.pone.0002636","article-title":"Phase 1 trial of malaria transmission-blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51","volume":"3","author":"Wu","year":"2008","journal-title":"PLoS ONE"},{"key":"R8-20250307","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1590\/S0074-02762010000100001","article-title":"Transmission blocking vaccines to control insect-borne diseases - A Review","volume":"105","author":"Coutinho-Abreu","year":"2010","journal-title":"Mem Inst Oswaldo Cruz, Rio de Janeiro"},{"key":"R9-20250307","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/15058","article-title":"Advances in vaccine adjuvants","volume":"17","author":"Singh","year":"1999","journal-title":"Nat Biotechnol"},{"key":"R10-20250307","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12026-008-8076-3","article-title":"DNA vaccines: developing new strategies to enhance immune responses","volume":"42","author":"Abdulhaqq","year":"2008","journal-title":"Immunol Res"},{"key":"R11-20250307","doi-asserted-by":"crossref","first-page":"13461","DOI":"10.1073\/pnas.0702239104","article-title":"Disruption of Plasmodium falciparum development by antibodies against a conserved mosquito midgut antigen","volume":"104","author":"Dinglasan","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"R12-20250307","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.cell.2004.10.009","article-title":"A role for insect galectins in parasite survival","volume":"119","author":"Kamhawi","year":"2004","journal-title":"Cell"},{"key":"R13-20250307","first-page":"1437","article-title":"Advances and challenges in malaria vaccine development","volume":"20","author":"Birkholtz","year":"2021","journal-title":"Expert Rev Vaccines"},{"key":"R14-20250307","first-page":"1171","article-title":"Editorial: Malaria vaccine development: Persistent challenges, but hope for the future","volume":"94","author":"Kaslow","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"R15-20250307","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","article-title":"Efficacy and safety of RTS, S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of phase 3, individually randomized, controlled trial","volume":"386","year":"2015","journal-title":"The Lancet"},{"key":"R16-20250307","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41541-017-0035-3","article-title":"Advances in malaria vaccine development: report from the 2017 malaria vaccine symposium","volume":"2","author":"Atre","year":"2017","journal-title":"NPJ Vaccines"},{"key":"R17-20250307","first-page":"3151","article-title":"Rationale for the Development of an Asexual Blood-Stage malaria vaccine","volume":"214","author":"Nussenzweig","year":"2017","journal-title":"Exp Med"},{"key":"R18-20250307","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.micinf.2008.05.004","article-title":"Mosquito-based transmission-blocking vaccines for interrupting Plasmodium development","volume":"10","author":"Lavazec","year":"2008","journal-title":"Microbes Infect"},{"key":"R19-20250307","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1242\/jeb.01066","article-title":"Innate immunity in the malaria vector Anopheles gambiae: comparative and functional genomics","volume":"207","author":"Osta","year":"2004","journal-title":"The Journal of Experimental Biology"},{"issue":"2","key":"R20-20250307","doi-asserted-by":"crossref","first-page":"e1003931","DOI":"10.1371\/journal.ppat.1003931","article-title":"Transmission-Blocking Antibodies against Mosquito C-Type Lectins for Dengue Prevention","volume":"10","author":"Liu","year":"2014","journal-title":"PLoS Pathog"},{"key":"R21-20250307","doi-asserted-by":"crossref","first-page":"640367","DOI":"10.3389\/fimmu.2021.640367","article-title":"Transgenic Expression of Human C-Type Lectin Protein CLEC18A Reduces Dengue Virus Type 2 Infectivity in Aedes aegypti","volume":"12","author":"Cheng","year":"2021","journal-title":"Front Immunol"},{"key":"R22-20250307","doi-asserted-by":"crossref","first-page":"104010","DOI":"10.1016\/j.dci.2021.104010","article-title":"Genetic determinants of antiviral immunity in dipteran insects - Compiling the experimental evidence","volume":"119","author":"Machado","year":"2021","journal-title":"Developmental and Comparative Immunology"},{"key":"R23-20250307","doi-asserted-by":"crossref","first-page":"82e9","DOI":"10.1016\/j.ibmb.2014.06.005","article-title":"Characterization of the Rel2-regulated transcriptome and proteome of Anopheles stephensi identifies new anti-Plasmodium factors","volume":"52","author":"Pike","year":"2014","journal-title":"Insect Biochemistry and Molecular Biology"},{"key":"R24-20250307","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/ijerph10010249","volume":"10","author":"Tabachnick","year":"2013","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"R25-20250307","doi-asserted-by":"crossref","first-page":"e4549","DOI":"10.1371\/journal.pone.0004549","article-title":"Molecular evolution of immune genes in the malaria mosquito Anopheles gambiae","volume":"4","author":"Lehmann","year":"2009","journal-title":"PLoS ONE"},{"key":"R26-20250307","doi-asserted-by":"crossref","first-page":"20130432","DOI":"10.1098\/rstb.2013.0432","article-title":"Heritable strategies for controlling insect vectors of disease","volume":"369","author":"Burt","year":"2014","journal-title":"Philos Trans R Soc B: Biol Sci"},{"key":"R27-20250307","doi-asserted-by":"crossref","first-page":"e03401","DOI":"10.7554\/eLife.03401","article-title":"Concerning RNA-guided gene drives for the alteration of wild populations","volume":"3","author":"Esvelt","year":"2014","journal-title":"eLife"},{"key":"R29-20250307","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1146\/annurev-ento-011613-162002","article-title":"Genetic control of mosquitoes","volume":"59","author":"Alphey","year":"2014","journal-title":"Annu Rev Entomol"},{"key":"R30-20250307","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1126\/science.aac7932","article-title":"Safeguarding gene drive experiments in the laboratory","volume":"349","author":"Akbari","year":"2015","journal-title":"Science"},{"key":"R31-20250307","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1126\/science.aab1028","article-title":"Biotechnology. A prudent path forward for genomic engineering and germline gene modification","volume":"348","author":"Baltimore","year":"2015","journal-title":"Science"},{"key":"R32-20250307","first-page":"124","article-title":"DNA vaccines: Are they still a viable option? Hum","volume":"17","author":"Schalk","year":"2021","journal-title":"Vaccines Immunother"},{"key":"R33-20250307","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"R34-20250307","first-page":"1051","article-title":"Vaccines: Correlates of vaccine-induced immunity","volume":"65","author":"Plotkin","year":"2017","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Vector Borne Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/JVBD.JVBD_157_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:32:09Z","timestamp":1787772729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/JVBD.JVBD_157_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/jvbd.jvbd_157_23","relation":{},"ISSN":["0972-9062"],"issn-type":[{"value":"0972-9062","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,12]]},"assertion":[{"value":"2023-09-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}